Dementia Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Most common cause of dementia in the UK

A

Alzheimer’s disease followed by vascular and lewy body dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which assessment tools are recommended for use in dementia

A

10-point cognitive screener(10-CS)

6-item cognitive impairment(6CIT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factor for alzheimer’s disease

A

Down’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Macroscopic pathological changes in alzheimer’s disease

A

Widespread cerebral atrophy, particularly involving the cortex and hippocampus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Microscopic pathological changes in alzheimer’s disease

A

Cortical plaques due to deposition of type A beta-amyloid protein and intraneuronal neurofibrillary tangles caused by abnormal aggregation of the tau protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Biochemical pathological changes in alzheimer’s disease

A

There is a deficit of acetylcholine from damage to an ascending forebrain projection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-pharmacological management of alzheimer’s disease

A

Range of activities to promote wellbeing that are tailored to person’s preference

Group cognitive stimulation therapy for patients with mild and moderate dementia

Group reminiscence therapy and cognitive rehabilitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacological management of alzheimer’s disease

A

Acetylcholinesterase inhibitors(donepezil, galatamine and rivastigmine)

Memantine second line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In which situations is memantine recommended in management of alzheimer’s disease

A

Moderate alzheimer’s who are intolerant of, or have a contraindication to, acetylcholinesterase inhibitors

As an add-on drug to acetylcholinesterase inhibitors for patients with moderate or severe alzheimer’s

Monotherapy in severe alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is donepezil contraindicated

A

Bradycardia

Adverse effects include insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristic pathological feature in lewy body dementia

A

Alpha-synuclein cytoplasmic inclusions(lewy bodies) in the substantia nigra, paralimbic and neocortical areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of lewy body dementia

A

Progressive cognitive impairment(early impairments in attention and executive function rather than just memory loss)

Cognition may be fluctuating(usually before parkinsonism)

Parkinsonism

Visual hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnosis of lewy body dementia

A

Usually clinical

Single-photon emission computed tomography(SPECT) is increasingly used(also known as DaTscan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of lewy body dementia

A

Acetylcholinesterase inhibitors and memantine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which medications should be avoided in lewy body dementia

A

Neuroleptics as patients are extremely sensitive and may develop irreversible parkinsonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is vascular dementia

A

Not a single disease but a group of syndromes of cognitive impairment caused by different mechanisms causing ischaemia or haemorrhage secondary to cerebrovascular disease

17
Q

Main subtypes of vascular dementia

A

Stroke-related VD - multi-infarct or single-infarct dementia

Subcortical VD - caused by small vessel disease

Mixed dementia - presence of both VD and alzheimer’s disease